You might think of cancer as a mass of rogue cells that grow uncontrollably. But cancer is more organized and strategic than ...

A molecular geneticist at Montana State University has discovered a cellular process once believed impossible by scientists – ...

How do different cancer subtypes arise? Do they originate from distinct cells, or from a single multipotent cell capable of ...

Many of the deadliest forms of cancer are caused by a pathological mutation in the RAS protein. Yet, to date, no effective ...

In a recent study, Stevens researchers have shown how colorectal cancers can evolve from mature intestinal cells that revert ...

ZFTA–RELA is the cancer-promoting protein product of a gene fusion. Analyses of accessible sites in the DNA–protein complex chromatin in developing mice show that ZFTA–RELA binds to chromatin modules ...

Scientists at Pune's Agharkar Research Institute developed a nanomedicine targeting breast cancer cells by silencing key ...

Immunotherapy, which uses programmed immune cells to selectively destroy cancer cells, has transformed cancer treatment. However, cancer cells have developed immune evasion strategies, leading to poor ...

Anocca AB (‘Anocca’ or the ‘Company’), a clinical-stage biotechnology company developing advanced T-cell immunotherapies, today announced the successful dosing of the first patients across multiple ...

As part of a clinical study, the Early Clinical Trial Unit (ECTU) at NCT/UCC Dresden tested the cancer immunotherapy IMA401 ...